FDA Approved: CERETEC — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)

View source ↗

Summary

FDA approves a supplemental application for CERETEC (TECHNETIUM TC-99M EXAMETAZIME) from Medi-Physics Inc. dba GE Healthcare.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cerebral Ischemia
• Dementia
• Epilepsy
• Stroke
• Traumatic Brain Injury

Drugs mentioned

• CERETEC (TECHNETIUM TC-99M EXAMETAZIME; TECHNETIUM TC-99M EXAMETAZIME AND COBALTOUS CHLORIDE)

Snippet

SUPPL AP for CERETEC (TECHNETIUM TC-99M EXAMETAZIME)